TRVI Next Earnings Date Notes

— Trevi Therapeutics (NASDAQ: TRVI) is a clinical-stage biopharmaceutical company focused on developing therapies for serious conditions with significant unmet needs, primarily targeting central & peripheral pruritus (itch) and chronic cough. The company's lead investigational candidate, Haduvio™ (oral nalbuphine extended release), is being developed for prurigo nodularis and severe chronic cough associated with idiopathic pulmonary fibrosis, aiming to bring relief to patients lacking effective options. For investors, key business metrics to track include clinical trial progress and results, especially any updates around Haduvio’s pivotal Phase 2b/3 studies, as regulatory milestones like positive top-line data can drive substantial value. It's also crucial to monitor the company's cash runway & burn rate, as continued R&D requires sufficient funding. Partnering activities, licensing deals, and regulatory feedback from the FDA & other health agencies should also be on your radar, since these will impact the company's go-to-market prospects and long-term viability. As you listen to the next earnings call, pay special attention to management's comments on trial recruitment, data timelines, financial flexibility, and their outlook on competitive positioning in the landscape of pruritus therapies. The next projected earnings date for TRVI is 11/12/2026 after close (stay tuned for a confirmed earnings date once announced).

TRVI Next Earnings Date FAQ

On this page we presented the TRVI Next Earnings Date information for Trevi Therapeutics along with recent past earnings dates. For Q2 of 2026, TRVI reported earnings of -0.110/share, with the earnings report taking place on 8/6/2026. For Q1 of 2026, TRVI reported earnings of -0.090/share, with the earnings report taking place on 5/5/2026. For Q4 of 2025, TRVI reported earnings of -0.060/share, with the earnings report taking place on 3/17/2026. For Q3 of 2025, TRVI reported earnings of -0.080/share, with the earnings report taking place on 11/13/2025. For Q2 of 2025, TRVI reported earnings of -0.090/share, with the earnings report taking place on 8/7/2025. Based on these past earnings dates, the projected next earnings date for TRVI is 11/12/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Trevi Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Trevi Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Trevi Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next TRVI earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up TRVI's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the TRVI next earnings date.